Tag Archives: Jonathan Kerr

Early growth response gene upregulation in Epstein-Barr Virus (EBV)- associated ME/CFS

Posted on 11/03/2020 by wames

Early growth response gene upregulation in Epstein-Barr Virus (EBV)- associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), by Jonathan Kerr in Biomolecules Vol 10, #11, p 1484,  Oct 26, 2020 [doi.org/10.3390/biom10111484]   Research abstract: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Early growth response gene upregulation in Epstein-Barr Virus (EBV)- associated ME/CFS

Responses in BMJ to Prof Sharpe on PACE trial

Posted on 09/05/2018 by wames

 Pressure grows on Lancet to review “flawed” PACE trial On 22 August Ingrid Torjesen  wrote a news item in the British Medical Journal about an article in the Times which highlighted the call to review the results of the PACE trial into … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on Responses in BMJ to Prof Sharpe on PACE trial

ME/CFS in Colombian workers

Posted on 08/11/2016 by wames

Research abstract: Background: Chronic Fatigue Syndrome/Myalgic encephalomyelitis (CFS/ME) is a debilitating and complex disease characterised by intense fatigue and a variety of other symptoms, which are present for at least 6 months. Studies of CFS/ME in the working population are … Continue reading →

Posted in News | Tagged , , , | Comments Off on ME/CFS in Colombian workers